Leader
|
|
|
00000nz a2200037n 45 0 |
001
|
|
|
LC|n 2016184099
(VIAF cluster)
(Authority/Source Record)
|
005
|
|
|
20160506053551.0 |
008
|
|
|
160505n| azannaabn |n aaa |
003
|
|
|
LC |
035
|
|
|
‡a
(LC)10154320
|
010
|
|
|
‡a
n 2016184099
|
035
|
|
|
‡a
(DNLM)1694051
|
035
|
|
|
‡a
(DLC)10151648
|
035
|
|
|
‡a
(DLC)n 2016184099
|
040
|
|
|
‡a
DNLM
‡b
eng
‡c
DNLM
‡e
rda
|
100
|
1 |
|
‡a
Johnson, Barton S.
|
670
|
|
|
‡a
Pharmacology and therapeutics for dentistry, 2017:
‡b
ECIP title page (Barton S. Johnson, DDS, MS; Director, General Swedish Residency Program Swedish Medical Center; Private Practice, Seattle Special Care Dentistry, Seattle, Washington)
|
901
|
|
|
‡a
978032339307
‡9
1
|
903
|
|
|
‡a
2016020799
‡9
1
|
910
|
|
|
‡a
pharmacologyandtherapeuticsfordentistry
‡A
Pharmacology and therapeutics for dentistry /
‡l
eng
‡9
1
|
919
|
|
|
‡a
pharmacologyandtherapeuticsfordentistry
‡A
Pharmacology and therapeutics for dentistry, 2017:
‡9
1
|
920
|
|
|
‡a
978-032
‡9
1
|
921
|
|
|
‡a
elsevier
‡b
Elsevier,
‡9
1
|
922
|
|
|
‡a
mou
‡b
us
‡9
1
|
940
|
|
|
‡a
eng
‡9
1
|
941
|
|
|
‡a
editor
‡e
editor.
‡9
1
|
942
|
|
|
‡a
RM300
‡9
1
|
943
|
|
|
‡a
201x
‡9
2
|
944
|
|
|
‡a
am
‡9
1
|
950
|
|
|
‡a
dowd frank j
‡A
Dowd, Frank J.,
‡d
1939-
‡9
1
|
950
|
|
|
‡a
mariotti angelo j
‡A
Mariotti, Angelo J.,
‡9
1
|
996
|
|
|
‡2
NTA|141949767
|
996
|
|
|
‡2
WKP|Q125512074
|
996
|
|
|
‡2
WKP|Q114067347
|
996
|
|
|
‡2
ISNI|0000000021918313
|
996
|
|
|
‡2
NII|DA02743323
|
996
|
|
|
‡2
DBC|87097919427757
|
996
|
|
|
‡2
DBC|87097991128284
|
996
|
|
|
‡2
J9U|987007332301405171
|
996
|
|
|
‡2
J9U|987008729761205171
|
996
|
|
|
‡2
WKP|Q89796761
|
996
|
|
|
‡2
BIBSYS|90861605
|
996
|
|
|
‡2
WKP|Q116788605
|
996
|
|
|
‡2
WKP|Q94281568
|
996
|
|
|
‡2
BIBSYS|90239774
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
998
|
|
|
‡a
Johnson, Barton S.
‡2
SUDOC|199210721
‡3
standard number
|
998
|
|
|
‡a
Johnson, Barton S.
‡2
J9U|987008729761205171
‡3
lccn:n2016-184099
‡3
viafid
|
999
|
|
|
‡2
LCBIB|2016020799
|